BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mota F, Jadhav R, Ruiz-Bedoya CA, Ordonez AA, Klunk MH, Freundlich JS, Jain SK. Radiosynthesis and Biodistribution of 18F-Linezolid in Mycobacterium tuberculosis-Infected Mice Using Positron Emission Tomography. ACS Infect Dis 2020;6:916-21. [PMID: 32243132 DOI: 10.1021/acsinfecdis.9b00473] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Lawal IO, Abubakar S, Ankrah AO, Sathekge MM. Molecular Imaging of Tuberculosis. Semin Nucl Med 2023;53:37-56. [PMID: 35882621 DOI: 10.1053/j.semnuclmed.2022.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mota F, Ruiz-Bedoya CA, Tucker EW, Holt DP, De Jesus P, Lodge MA, Erice C, Chen X, Bahr M, Flavahan K, Kim J, Brosnan MK, Ordonez AA, Peloquin CA, Dannals RF, Jain SK. Dynamic (18)F-Pretomanid PET imaging in animal models of TB meningitis and human studies. Nat Commun 2022;13:7974. [PMID: 36581633 DOI: 10.1038/s41467-022-35730-3] [Reference Citation Analysis]
3 Karpuz M, Özgenç E, Gündoğdu E, Burak Z. Enfeksiyon Görüntüleme ve Tedavisi için 177Lutesyum-Tedizolid. Fabad J Pharm Sci 2022. [DOI: 10.55262/fabadeczacilik.1099287] [Reference Citation Analysis]
4 Gouws AC, Kruger HG, Gheysens O, Zeevaart JR, Govender T, Naicker T, Ebenhan T. Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or "Unclear" Infection Imaging? Angew Chem Int Ed Engl 2022;61:e202204955. [PMID: 35834311 DOI: 10.1002/anie.202204955] [Reference Citation Analysis]
5 Huynh J, Donovan J, Phu NH, Nghia HDT, Thuong NTT, Thwaites GE. Tuberculous meningitis: progress and remaining questions. The Lancet Neurology 2022;21:450-64. [DOI: 10.1016/s1474-4422(21)00435-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Dadachova E, Rangel DEN. Highlights of the Latest Developments in Radiopharmaceuticals for Infection Imaging and Future Perspectives. Front Med 2022;9:819702. [DOI: 10.3389/fmed.2022.819702] [Reference Citation Analysis]
7 More S, Marakalala MJ, Sathekge M. Tuberculosis: Role of Nuclear Medicine and Molecular Imaging With Potential Impact of Neutrophil-Specific Tracers. Front Med 2021;8:758636. [DOI: 10.3389/fmed.2021.758636] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yang HJ, Wang D, Wen X, Weiner DM, Via LE. One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics. Front Cell Infect Microbiol 2021;11:613149. [PMID: 33796474 DOI: 10.3389/fcimb.2021.613149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ordonez AA, Tucker EW, Anderson CJ, Carter CL, Ganatra S, Kaushal D, Kramnik I, Lin PL, Madigan CA, Mendez S, Rao J, Savic RM, Tobin DM, Walzl G, Wilkinson RJ, Lacourciere KA, Via LE, Jain SK. Visualizing the dynamics of tuberculosis pathology using molecular imaging. J Clin Invest 2021;131:145107. [PMID: 33645551 DOI: 10.1172/JCI145107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ordoñez AA, Jain SK. Imaging of Bacterial Infections. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00089-2] [Reference Citation Analysis]
11 Tambe V, Kathar U, Raval N, Rajpoot K, Shilpi S, Khatri K, Tekade RK. Positron emission tomography as a noninvasive tool in pharmacokinetic studies. Biopharmaceutics and Pharmacokinetics Considerations 2021. [DOI: 10.1016/b978-0-12-814425-1.00013-9] [Reference Citation Analysis]